Novartis AG (NVS) Stock Score, Valuation & Financial Research
Novartis AG is in the Healthcare sector and Drug Manufacturers - General industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 47/100.
Quick answer for NVS
Novartis AG currently has a Wall Street Score of 47/100. The stored market price is $138.99. Its financial score is 31/100. Its valuation score is 61/100. These figures are a research snapshot, not a buy or sell recommendation.
What Novartis AG does
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
NVS financial snapshot
- Wall Street Score:
- 47/100
- Current price:
- $138.99
- Market capitalization:
- $264.18B
- Revenue:
- $55.63B
- Net income:
- $12.76B
- Free cash flow:
- $17.69B
- Cash:
- $7.62B
- Total debt:
- $49.01B
- EPS:
- 7.25
- P/E ratio:
- 19.2x
- Financial score:
- 31/100
- Valuation score:
- 61/100
- Revenue score:
- 24/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $17.69B, showing positive cash generation.
- The balance sheet shows $7.62B of cash versus $49.01B of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 61/100, which Wall Street Score classifies as mixed within the model's valuation framework.
The financial score is 31/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research NVS
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.